Concepedia
9
Publications
779
Citations
H-Index
2001
Active since
Affiliations
KU Leuven(Current)
Délégation Paris 5
Université Paris Cité
Veerle Bulteel is an author at KU Leuven specializing in clinical trial design, health sciences, and medicine.
Top concepts
HealthMedicineClinical TrialsClinical Trial Design
Publications per year
2001–2016
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
Peter Suenaert, Veerle Bulteel, Liesbeth Lemmens et al. · The American Journal of Gastroenterology · 2002 · 386 citations
Anti-Saccharomyces Cerevisiae Antibodies (ASCA), Phenotypes of IBD, and Intestinal Permeability: A Study in IBD Families
Séverine Vermeire, Marc Peeters, Robert Vlietinck et al. · Inflammatory Bowel Diseases · 2001 · 179 citations · Full text
Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway
Vicky De Preter, Karel Geboes, Veerle Bulteel et al. · Alimentary Pharmacology & Therapeutics · 2011 · 45 citations · Full text
Pouchitis, Similar to Active Ulcerative Colitis, Is Associated with Impaired Butyrate Oxidation by Intestinal Mucosa
Vicky De Preter, Veerle Bulteel, Peter Suenaert et al. · Inflammatory Bowel Diseases · 2008 · 40 citations · Full text
Hyperresponsiveness of the Mucosal Barrier in Crohnʼs Disease Is Not Tumor Necrosis Factor-Dependent
Peter Suenaert, Veerle Bulteel, Séverine Vermeire et al. · Inflammatory Bowel Diseases · 2005 · 35 citations · Full text
Rows per page
1–5 of 9